Impact of recombinant human growth hormone (rh-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults: a placebo - controlled trial

Author:

SOARES CLÁUDIO DE NOVAES1,MUSOLINO NINA ROSA1,CUNHA NETO MALEBRANCHE1,CAIRES MARIA ADELAIDE1,ROSENTHAL MARIA CRISTINA1,CAMARGO CANDIDA PIRES1,BRONSTEIN MARCELLO D.1

Affiliation:

1. University of Sao Paulo, Brazil; University of Sao Paulo

Abstract

BACKGROUND: Untreated GH-deficient adults have a diversity of dysfunctions (e.g. reduced muscle strength, emotional instability during stress, depressive symptoms) that may cause deleterious effects on quality of life, and may be positively influenced by recombinant human growth hormone (rh-GH) therapy. AIM: To evaluate the impact of a clinical intervention with rh-GH therapy on GH - deficient adults. METHOD: The physical, psychiatric and neuropsychological status of 9 GH-deficient adults was determined before and after the administration of rh-GH (0.250 IU/Kg/week) in a double blind placebo-controlled trial for six months. Patients then received rh-GH for a further period of 6 months and their status was re-evaluated. RESULTS: Rh-GH was significant better than placebo at 6th month (p<0.05), producing increased serum Insulin like growth factor-I (IGF-1) levels, reduced body mass index (BMI) and body fat, increased lean body mass and water, reduced waist/hip ratio and increased energy expenditure. The rh-GH therapy was also significantly better than placebo on depressive features as measured by the Hamilton Depression Scale (17-items) (p= 0.0431) and the Beck Depression Inventory (p= 0.0431). Neuropsychological evaluations showed significant improvements in measures of Attention: Digit Backward (p= 0.035),Verbal Fluency (FAS) (p= 0.02) and Cognitive Efficiency (WAIS-R tests): Vocabulary (p= 0.027) , Picture Arrangements (p= 0.017), and Comprehension (p= 0.01) following rh-GH therapy. CONCLUSION: The clinical, psychiatric, and neuropsychological impairments of untreated GH-deficient adults can be decreased by rh-GH therapy.

Publisher

FapUNIFESP (SciELO)

Subject

Neurology,Clinical Neurology

Reference27 articles.

1. The educational vocational and marital status of growth hormone-deficient adults treated with growth hormone during childhood;Dean HJ;Am J Dis Child,,1985

2. Adult growth hormone deficiency;Jorgensen JOL;Horm Res,1984

3. Quality of life in adults with growth hormone (GH) deficiency; response to treatment with recombinat human GH in placebo-controlled month trial;Burman P;J Clin Endocrinol Metab,1995

4. Quality of life of adults with growth hormone deficiency: a controlled study;Björk S;Acta Paediatr Scand,1989

5. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency;McGauley GA;Acta Paediatr Scand,1989

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3